Journal of Cell Science, Vol 109, Issue 7 1957-1964, Copyright © 1996 by Company of Biologists

JOURNAL ARTICLES

Migration of highly aggressive melanoma cells on hyaluronic acid is associated with functional changes, increased turnover and shedding of CD44 receptors

M Goebeler, D Kaufmann, EB Brocker and CE Klein
Department of Dermatology, University of Wurzburg, Germany.

Recent evidence indicates that CD44, a multifunctional adhesion receptor involved in cell-cell as well as in cell-matrix interactions, plays an important role in local progression and metastasis of malignant tumors. We have studied a set of human melanoma cell lines differing in their metastatic potential in nude mice as well as in normal melanocytes for changes in CD44 expression and function. All melanocytes and melanoma cell lines tested highly expressed the CD44 standard form (CD44s, 85 kDa) but variants at low levels only. With respect to one of the CD44-associated functions primarily involved in tumor progression we found that two highly metastatic tumor cell lines, MV3 and BLM, showed fivefold higher migration rates towards hyaluronate than melanomas with low metastatic potential and normal melanocytes. Moreover, the highly metastatic cell lines expressed four- to sixfold higher levels of the CD44 epitope involved in hyaluronic acid-binding (monoclonal antibody Hermes-1) than less aggressive melanomas and melanocytes. Hermes-1 efficiently blocked haptotaxis to hyaluronate, supporting the functional relevance of this epitope. In contrast, expression levels of other CD44s epitopes recognized by seven different anti-CD44 monoclonal antibodies were unchanged, suggesting that the migratory behaviour of the cells depends on the formation of the hyaluronate-binding Hermes-1 epitope rather than on the overall CD44s surface expression, which was virtually identical in all melanoma and melanocyte cell lines tested. Differences in the accessibility of the hyaluronate-binding epitope defined by Hermes-1 correlated with the phosphorylation state of CD44s, probably reflecting different activation states of the receptor. Furthermore, immunoprecipitation and pulse/chase studies revealed a three- to fivefold increase in CD44 synthesis in the highly aggressive melanoma cells as compared to the other cell lines and the melanocytes, indicating a reduction of CD44 half-life and up-regulation of turnover. Moreover, highly aggressive melanoma cell lines were found to shed significant amounts of CD44 from the cell surface and to secrete its ligand hyaluronic acid, which may refer to an "autocrine' mechanism mediating melanoma cell motility.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S. R. Hamilton, S. F. Fard, F. F. Paiwand, C. Tolg, M. Veiseh, C. Wang, J. B. McCarthy, M. J. Bissell, J. Koropatnick, and E. A. Turley The Hyaluronan Receptors CD44 and Rhamm (CD168) Form Complexes with ERK1,2 That Sustain High Basal Motility in Breast Cancer Cells J. Biol. Chem., June 1, 2007; 282(22): 16667 - 16680. [Abstract] [Full Text] [PDF]

				L. Pelletier, P. Guillaumot, B. Freche, C. Luquain, D. Christiansen, S. Brugiere, J. Garin, and S. N. Manie {gamma}-Secretase-Dependent Proteolysis of CD44 Promotes Neoplastic Transformation of Rat Fibroblastic Cells. Cancer Res., April 1, 2006; 66(7): 3681 - 3687. [Abstract] [Full Text] [PDF]

				H. Nakamura, N. Suenaga, K. Taniwaki, H. Matsuki, K. Yonezawa, M. Fujii, Y. Okada, and M. Seiki Constitutive and Induced CD44 Shedding by ADAM-Like Proteases and Membrane-Type 1 Matrix Metalloproteinase Cancer Res., February 1, 2004; 64(3): 876 - 882. [Abstract] [Full Text] [PDF]

				H. Matsuki, K. Yonezawa, K.'i. Obata, K. Iwata, H. Nakamura, Y. Okada, and M. Seiki Monoclonal Antibodies with Defined Recognition Sequences in the Stem Region of CD44: Detection of Differential Glycosylation of CD44 between Tumor and Stromal Cells in Tissue Cancer Res., December 1, 2003; 63(23): 8278 - 8283. [Abstract] [Full Text] [PDF]

				I. Gal, J. Lesley, W. Ko, A. Gonda, R. Stoop, R. Hyman, and K. Mikecz Role of the Extracellular and Cytoplasmic Domains of CD44 in the Rolling Interaction of Lymphoid Cells with Hyaluronan under Physiologic Flow J. Biol. Chem., March 21, 2003; 278(13): 11150 - 11158. [Abstract] [Full Text] [PDF]

				M. Kajita, Y. Itoh, T. Chiba, H. Mori, A. Okada, H. Kinoh, and M. Seiki Membrane-Type 1 Matrix Metalloproteinase Cleaves Cd44 and Promotes Cell Migration J. Cell Biol., May 28, 2001; 153(5): 893 - 904. [Abstract] [Full Text] [PDF]

				S.-H. Leir, J. E. Baker, S. T. Holgate, and P. M. Lackie Increased CD44 expression in human bronchial epithelial repair after damage or plating at low cell densities Am J Physiol Lung Cell Mol Physiol, June 1, 2000; 278(6): L1129 - L1137. [Abstract] [Full Text] [PDF]

				K. Maaser, K. Wolf, C. E. Klein, B. Niggemann, K. S. Zänker, E.-B. Bröcker, and P. Friedl Functional Hierarchy of Simultaneously Expressed Adhesion Receptors: Integrin alpha 2beta 1 but Not CD44 Mediates MV3 Melanoma Cell Migration and Matrix Reorganization within Three-dimensional Hyaluronan-containing Collagen Matrices Mol. Biol. Cell, October 1, 1999; 10(10): 3067 - 3079. [Abstract] [Full Text]

				I. Okamoto, Y. Kawano, M. Matsumoto, M. Suga, K. Kaibuchi, M. Ando, and H. Saya Regulated CD44 Cleavage under the Control of Protein Kinase C, Calcium Influx, and the Rho Family of Small G Proteins J. Biol. Chem., September 3, 1999; 274(36): 25525 - 25534. [Abstract] [Full Text] [PDF]

				I. M. S. Dahl, I. Turesson, E. Holmberg, and K. Lilja Serum Hyaluronan in Patients With Multiple Myeloma: Correlation With Survival and Ig Concentration Blood, June 15, 1999; 93(12): 4144 - 4148. [Abstract] [Full Text] [PDF]

				W Hayen, M Goebeler, S Kumar, R Riessen, and V Nehls Hyaluronan stimulates tumor cell migration by modulating the fibrin fiber architecture J. Cell Sci., January 7, 1999; 112(13): 2241 - 2251. [Abstract] [PDF]

				D Peck and C. Isacke Hyaluronan-dependent cell migration can be blocked by a CD44 cytoplasmic domain peptide containing a phosphoserine at position 325 J. Cell Sci., January 6, 1998; 111(11): 1595 - 1601. [Abstract] [PDF]